Literature DB >> 9117557

Pyramidal nerve cell loss in Alzheimer's disease.

D M Mann1.   

Abstract

Loss of the large pyramidal cells of the association neocortex and hippocampus, along with plaques and tangles, is fundamental to the neuropathology of Alzheimer's disease. The extent of Alzheimer-specific cell loss, relative to controls, is age-dependent with maximal losses in younger subjects though, because of the (additive) effects of 'normal' ageing on such cells, the absolute loss remains constant at all ages. The cause of the cell loss remains unknown but probably relates to neurofibrillary degeneration through a crowding out of organelles and a disruption of intracellular transport; oxidative stress may also contribute. The degree of clinical dementia correlates well with the extent of pyramidal cell loss.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9117557     DOI: 10.1006/neur.1996.0057

Source DB:  PubMed          Journal:  Neurodegeneration        ISSN: 1055-8330


  18 in total

1.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Myths and truths about the cellular composition of the human brain: A review of influential concepts.

Authors:  Christopher S von Bartheld
Journal:  J Chem Neuroanat       Date:  2017-09-02       Impact factor: 3.052

3.  Quantum-like behavior without quantum physics III : Logic and memory.

Authors:  Stephen Selesnick; Gualtiero Piccinini
Journal:  J Biol Phys       Date:  2019-10-15       Impact factor: 1.365

Review 4.  Calcium-regulated signaling pathways: role in amyloid beta-induced synaptic dysfunction.

Authors:  Cui-Wei Xie
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 5.  Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment.

Authors:  Saeid Bagheri-Mohammadi
Journal:  Cell Tissue Bank       Date:  2021-01-04       Impact factor: 1.522

Review 6.  The cholinergic hypothesis of Alzheimer's disease: a review of progress.

Authors:  P T Francis; A M Palmer; M Snape; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

Review 7.  Neurodegeneration and cell replacement.

Authors:  Brandi K Ormerod; Theo D Palmer; Maeve A Caldwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

Review 8.  Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease. A review on the bioactivity of neuroprotectin D1 and apoptosis.

Authors:  Walter J Lukiw; Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.590

9.  Phenotypic assays for β-amyloid in mouse embryonic stem cell-derived neurons.

Authors:  Laura Beth J McIntire; Natalie Landman; Min Suk Kang; Gina M Finan; Jeremy C Hwang; Ann Z Moore; Lydia S Park; Chyuan-Sheng Lin; Tae-Wan Kim
Journal:  Chem Biol       Date:  2013-07-25

10.  Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology.

Authors:  Mitchell K P Lai; Michelle G K Tan; Sara Kirvell; Carl Hobbs; Jasinda Lee; Margaret M Esiri; Christopher P Chen; Paul T Francis
Journal:  J Neural Transm (Vienna)       Date:  2008-05-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.